Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Cogstate Ltd ( (AU:CGS) ).
Cogstate has reshaped its company secretarial structure, announcing the resignation of joint company secretary Kristi Geddes as she departs to pursue other opportunities. The board expressed appreciation for her contribution and confirmed that long-serving joint company secretary David Franks will remain in his role.
To maintain continuity in governance and compliance, the company has appointed chief financial officer Darren Watson as a new joint company secretary, effective 22 May 2026. Watson’s financial leadership and deep knowledge of Cogstate’s operations are expected to underpin stable communication with the ASX and reinforce the robustness of the company’s corporate governance framework.
The most recent analyst rating on (AU:CGS) stock is a Buy with a A$3.20 price target. To see the full list of analyst forecasts on Cogstate Ltd stock, see the AU:CGS Stock Forecast page.
More about Cogstate Ltd
Cogstate Ltd is a global central nervous system endpoint innovations company that partners with drug developers to support complex neuroscience studies. The group provides applied technology solutions, including data quality programs, advanced analytics, and digital cognitive testing, and also targets the healthcare market with brief, self-administered digital measures of cognition for primary care use.
Average Trading Volume: 133,479
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$429.2M
For a thorough assessment of CGS stock, go to TipRanks’ Stock Analysis page.